Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Select Medical Holdings Corporation (SEM) had Cost of Goods Sold of $4.82B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$5.45B
Net Income	$146.22M
Cost of Goods Sold	$4.82B
Gross Profit	$629.29M
Operating Expenses	$5.12B
Operating Income	$336.17M
Non-Operating Income/Expense	$-63.42M
Pre-Tax Income	$272.75M
Normalized Pre-Tax Income	$272.75M
Income after Taxes	$214.53M
Income from Continuous Operations	$214.53M
Consolidated Net Income/Loss	$214.53M
Normalized Income after Taxes	$214.53M
EBIT	$336.17M
EBITDA	$479.61M
Weighted-Average Shares Outstanding (Basic)	122.65M
Weighted-Average Shares Outstanding (Diluted)	122.65M
Earnings per Share (EPS) (Basic)	$1.16
Earnings per Share (EPS) (Diluted)	$1.16
Balance Sheet Financials
Current Assets	$1.03B
Property, Plant, and Equipment	$992.31M
Long-Term Assets	$4.83B
Total Assets	$5.85B
Current Liabilities	$984.49M
Long-Term Debt	$1.80B
Long-Term Liabilities	$2.85B
Total Liabilities	$3.83B
Common Equity	$2.02B
Tangible Shareholders Equity	$-444.77M
Shareholders Equity	$2.02B
Common Shares Outstanding	124.02M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$346.47M
Cash Flow from Investing Activities	$-216.49M
Cash Flow from Financial Activities	$-163.15M
Beginning Cash	$59.69M
End Cash	$26.52M
Increase/Decrease in Cash	$-33.17M
Stock-Based Compensation	$16.70M
Common Stock Dividends Paid	$-31.43M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.04
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.47
Debt to Equity Ratio	0.91
Gross Margin	11.54%
Operating Margin	6.17%
EBIT Margin	6.17%
EBITDA Margin	8.80%
Pre-Tax Profit Margin	5.00%
Profit Margin	2.68%
Free Cash Flow	$140.63M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.93
Inventory Turnover	--
Receiveable Turnover	6.17
Days Sales in Receivables	59.16
Return on Equity	10.64%
Return on Tangible Equity	-48.23%
Return on Assets	3.67%
Return on Investments	5.61%
Book Value Per Share	$16.26
Free Cash Flow per Share	$1.15
Operating Cash Flow per Share	$2.82

Data from Zacks Investment Research, Inc.